LUNG.NASDAQPulmonx CORP

Form 4: Pulmonx Corp Director Melenikiotou Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Director Georgia Melenikiotou of Pulmonx Corp [LUNG] received a grant of 15,216 common stock shares on June 3, 2024.

Summary

  • Georgia Melenikiotou, a director of Pulmonx Corp [LUNG], filed a Form 4 on June 5, 2024, reporting a transaction.
  • On June 3, 2024, Melenikiotou acquired 15,216 shares of common stock through a grant.
  • These shares were acquired at a price of $0.
  • Following the transaction, Melenikiotou directly owns 62,561 shares of Pulmonx Corp.
  • The grant represents Restricted Stock Units (RSU) that vest on the earlier of the one-year anniversary of the grant date (June 3, 2024) or the date of the next Annual Meeting of Stockholders.

Sentiment

Score: 7

Explanation: The document reflects a routine stock grant, which is generally viewed positively as it aligns management's interests with shareholders. There are no indications of negative sentiment.

Positives

  • The grant of stock to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The director's holdings will increase as the Restricted Stock Units vest, aligning their interests with the company's long-term performance.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to incentivize and retain key personnel.

Stakeholder Impact

  • Shareholders may view the stock grant positively as it aligns the director's interests with the company's performance.

Key Dates

DateDescription
06/03/2024Date of the stock grant transaction
06/05/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.